SEC Comment Letter 0000000000-22-012818 to Viveon Health Acquisition Corp. (CIK 0001823857)

Viveon Health Acquisition Corp. (CIK 0001823857)
Date: Nov. 28, 2022 · CIK: 0001823857 · Accession: 0000000000-22-012818

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-39827

Date

November 28, 2022

Author

Not clearly detected

Form

UPLOAD

Company

Viveon Health Acquisition Corp. (CIK 0001823857)

Letter

United States securities and exchange commission logo November 28, 2022 Jagi Gill Chief Executive Officer, President and Chairman Viveon Health Acquisition Corp. c/o Gibson, Deal & Fletcher, PC Spalding Exchange 3953 Holcomb Bridge Road Suite 200 Norcross, GA 30092 Re:Viveon Health Acquisition Corp. Preliminary Proxy Statement on Schedule 14A Filed November 1, 2022 File No. 001-39827 Dear Jagi Gill: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Tahra Wright, Esq.

Show Raw Text

United States securities and exchange commission logo
November 28, 2022
Jagi Gill
Chief Executive Officer, President and Chairman
Viveon Health Acquisition Corp.
c/o Gibson, Deal & Fletcher, PC
Spalding Exchange
3953 Holcomb Bridge Road
Suite 200
Norcross, GA 30092
Re:Viveon Health Acquisition Corp.
Preliminary Proxy Statement on Schedule 14A
Filed November 1, 2022
File No. 001-39827
Dear Jagi Gill:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Tahra Wright, Esq.

SecProbe.io